Gadolinium-DTPA enhancement of soft tissue tumors in magnetic resonance imaging--preliminary clinical experience in five patients.
In a preliminary report of a clinical trial of gadolinium-DTPA (Gd-DTPA) for enhancement of soft tissue tumors in magnetic resonance imaging (MRI), experience of the first five cases is presented. Enhancement was found to give better delineation of the tumor in richly vascularized parts of the tumors, compressed tissue immediately surrounding the tumor, and in atrophic, but richly vascularized, muscle.
Pettersson
H
H
Department of Diagnostic Radiology, University Hospital, Lund, Sweden.
Eliasson
J
J
Egund
N
N
Rööser
B
B
Willén
H
H
Rydholm
A
A
Berg
N O
NO
Holtås
S
S
D000328:Adult; D000368:Aged; D005260:Female; D005354:Fibrosarcoma / Q000175:diagnosis; D005682:Gadolinium; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D012516:Osteosarcoma / Q000175:diagnosis; D004369:Pentetic Acid; D013584:Sarcoma, Synovial / Q000175:diagnosis; D012983:Soft Tissue Neoplasms / Q000175:diagnosis*; D013581:Synovial Cyst / Q000175:diagnosis
D009942:Organometallic Compounds; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA